Amarin Corp Valuation Multiples

Amarin Corp Overview

About Amarin Corp

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Founded

1989

HQ

Employees

275

Website

amarincorp.com

Sectors

BiopharmaceuticalsBioTech

Financials (LTM)

Revenue: $203M

EBITDA: ($41M)

EV

$10M

Valuation Multiples

Multiples.vc

Start free trial

Amarin Corp Financials

Amarin Corp reported last 12-month revenue of $203M and negative EBITDA of ($41M).

In the same LTM period, Amarin Corp generated $114M in gross profit, ($41M) in EBITDA losses, and had net loss of ($25M).

Amarin Corp P&L

In the most recent fiscal year, Amarin Corp reported revenue of $214M and EBITDA of ($33M).

Amarin Corp expects next 12-month revenue of XXX and NTM EBITDA of XXX

Amarin Corp Stock Performance

Amarin Corp has current market cap of $306M, and enterprise value of $10M.

Amarin Corp's stock price is $14.73.

Amarin Corp Valuation Multiples

Amarin Corp trades at 0.0x EV/Revenue multiple, and (0.2x) EV/EBITDA.

Amarin Corp Financial Valuation Multiples

As of April 10, 2026, Amarin Corp has market cap of $306M and EV of $10M.

Equity research analysts estimate Amarin Corp's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Amarin Corp has a P/E ratio of (12.5x).

Amarin Corp Margins & Growth Rates

Amarin Corp's revenue in the last 12 month declined by (14%).

Amarin Corp's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.5M for the same period.

Amarin Corp's rule of 40 is (29%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Amarin Corp's rule of X is (57%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Amarin Corp Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Amarin Corp M&A Activity

Amarin Corp acquired XXX companies to date.

Last acquisition by Amarin Corp was on XXXXXXXX, XXXXX. Amarin Corp acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Amarin Corp Investment Activity

Amarin Corp invested in XXX companies to date.

Amarin Corp made its latest investment on XXXXXXXX, XXXXX. Amarin Corp invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).